Lilly Finalizes Novartis Animal Health Acquisition (NYSE:LLY)

INDIANAPOLIS, Jan. 1, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Novartis Animal Health, which will further position Lilly's Elanco as a global leader in the animal health industry. The transaction, first announced on April 22, has received clearance under the Hart-Scott-Rodino Antitrust Improvements Act. As part of the approval, certain animal health assets in the U.S. relating to the Sentinel^® canine parasiticide franchise will be divested to Virbac, as has been previously announced. All other closing conditions have also been met.



Lilly Finalizes Novartis Animal Health Acquisition (NYSE:LLY)